The effectiveness of ehealth interventions for weight loss and weight loss maintenance in adults with overweight or obesity: a systematic review of systematic reviews
GLP-1 Drugs present a promising avenue for intervention: Overlapping risk factors: Given the shared risk factors between diabetes and liver disease, the diabetic drug Ozempic is projected to become the second-highest-grossing treatment for NAFLD and NASH by 2028
It is not just about side effect management
Copper is a component of the enzyme tyrosinase, which is involved in the production of melanin, the pigment responsible for hair color
Official Details: Medication: Tirzepatide (identical to Mounjaro) Manufacturer: Eli Lilly FDA Approval: November 2023 Approved For: Chronic weight management in adults with obesity or overweight with weight-related conditions Dosing: Once-weekly injection Available Doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg List Price: $1,069 per month (same as Mounjaro) How Zepbound Differs from Mounjaro: The medications are completely identical
Gut Microbes 7(3):189200 Kobyliak N, Conte C, Cammarota G, Haley AP, Styriak I, Gaspar L et al (2016) Probiotics in prevention and treatment of obesity: a critical view
